Chronic daily headache and medication overuse headache: Clinical read-outs and rehabilitation procedures

Clinica Terapeutica

Volumn 158, Issue 4, 2007, Pages 343-347

  De Filippis, S ^a   Salvatori, E ^a   Farinelli, I ^a   Coloprisco, G ^a   Martelletti, Pablo ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Chronic daily headache; Management; Medication overuse headache; Rehabilitation

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN; CAFFEINE; CLONIDINE; ERGOT ALKALOID; GABAPENTIN; MONOAMINE OXIDASE INHIBITOR; OLANZAPINE; OPIATE; PLACEBO; PREGABALIN; SEROTONIN UPTAKE INHIBITOR; TIZANIDINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPTAN DERIVATIVE; VALPROIC ACID; VENLAFAXINE;

CHRONIC DAILY HEADACHE; CLINICAL TRIAL; DOSE RESPONSE; DRUG ABUSE; DRUG INDUCED HEADACHE; HUMAN; LOW DRUG DOSE; MIGRAINE; PREVALENCE; QUALITY OF LIFE; REHABILITATION CARE; REVIEW; UNSPECIFIED SIDE EFFECT;

ADULT; CHRONIC DISEASE; COMORBIDITY; EUROPE; HEADACHE; HUMANS; QUALITY OF LIFE; SUBSTANCE-RELATED DISORDERS; WORK;

EID: 34547683313     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. World Health Organization. Headache disorders and public health. WHO, Geneva, 2000
2. Stovner LJ, Zwart JA, Hagen K, et al. Epidemiology of headache in Europe. Eur J Neurol 2006; 13(4):333-46
3. Castillo J, Munoz P, Guitera V, et al. Epidemiology of chronic daily headache in the general population. Headache 1999; 39:190-6
4. Newman LC, Lipton RB, Solomon S, et al. Daily headache in a population semple: results from the American Migraine Study. Headache 1994; 34:295
5. Martelletti P, Leonardi M. The global impact of migraine. J Headache Pain 2003; 4(suppl.1):1-2
6. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders. 2d ed Cephalalgia 2004; 24(suppl 1): 9-160
7. Smith R. Chronic Daily Headach. Am Fam Physician 2004; 70:2299-306
8. Sandrini G, Proietti Cecchini A, Milanov I, et al. Electrophysiological evidence for trigeminal neuron sensitization in patients with migraine. Neurosci Lett 2002; 317:135-8
9. Burstein R. Deconstructing migraine headache into peripheral and central sensitisation. Pain 2001; 89:107-10
10. Strassman AM. Levy D. Response properties of dural nociceptors in relation to headache. J Neurophysiol 2006; 95(3):1298-306
11. Bahra A, Walsh M, Menon S, et al.: Does chronic daily headache arise de novo in association with regular use of analgesics. Headache 2003; 43:179-90
12. Tepper SJ. Analgesic overuse is a cause of chronic daily headache. Headache 2002; Â42:Â5:43-7
13. Dodick DW: Analgesic overuse is not a cause of chronic daily headache. Headache 2002; 42:547-54
14. Rainero I, Ferrero M, Rubino E, et al. Endocrine function is altered in chronic migraine patients with mediciation overuse headache. Headache 2006; 6:597-603
15. Patacchioli Fr, Monnazzi P, Simeoni S, et al. Salivary cortisol, dehydroepiandrosterone-sulphate (DHEA-S) and testosterone in women with chronic migraine. J Headache Pain 2006; 7(2):90-4
16. Silberstein SD, Olesen J, Bousser MG, et al. The International Classification of Headache Disorders, 2nd edn.-revision of criteria for 8.2 Medication-overuse headache Cephalalgia 2005; 25:460-5
17. Limmroth V, Katsarava Z, Fritsche G, et al. Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002; 59:1011-4
18. Calabresi P, Cupini LM. Medication overuse headache: similarities with drug addiction. Trends in Pharmacological Sciences 2005; 26(2):62-8
19. Young WB. Medication overuse Headache. Curr Treat Options. Neurology 2001; 3:181-8
20. Limmroth V, Kazarawa S, Fritsche G, et al. Features of medication overuse Headache following overuse of different acute headache drug, Neurology 2002; 59:1011-4
21. Diener HC, Dahöf CGH. Headache associated with chronic use of substances. In. Olesen J, Tfelt-Hasen P, Welch KMA, eds. The Headaches, 2nd ed. Phialdelphia, Lippincott, Williams &Wilkins, 1999; 871-8
22. Saper JR, Hamel RL, Lake AE III. Medication overuse headache (MOH) is a biobehavioural disorder. Cephalalgia 2005; 25:545-6
23. Radat F, Creac'h C, Swendsen JD, et al. Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia 2005; 25:519-22
24. De Filippis S, Salvatori E, Coloprisco G, et al. Headache and mood disorders. J Headache Pain 2005; 6:250-3
25. Atasoy HT, Atasoy N, Unal AE, et al. Psychiatric comorbidity in mediacation overuse headache patients with pre-existing headache type of episodic tension-type headache. European J Pain 2005; 9:285-91
26. Saper JR, Lake AE III. Borderline personality disorder and the chronic headache patient: review and management recommendation. Headache 2002; 42:663-74
27. Dowson AJ, Dodick DW, Limmroth V. Medication overuse headache in patients with primary headache disorders: epidemiology, management and pathogenesis. CNS Drugs 2005; 19:483-97
28. De Filippis S, Salvatori E, Cuomo I, et al. Rehabiltation procedures for medication overuse headache (MOH). J Headache Pain 2004; 5(suppl 1):S25
29. Brandes JL, Saper JR, Diamond M, et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004; 291:965-73
30. Silberstein SD, Neto W, Schmitt J, et al. MIGR-001 Study Group., Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 2004; 61:490-5
31. Freitag FG, Diamond S, Diamond ML, et al. Divalproex in the long-term treatment of chronic daily headache. Headache 2001; 41:271-8
32. Mathew NT, Kailasam J, Meadors L. Prophylaxis of migraine, transformed migraine, and cluster headache with Topiramate. Headache 2002; 42:796-803
33. Spira PJ, Baren RG. Gabapentin in the prophylaxis of Chronic Daily Headache: A randomized, placebo-controlled study. Neurology 2003; 61:1753-9
34. Punay NC, Couch JR: Antidepressants in the treatment of migraine headache. Curr Pain Headache Rep 2003; 7:51-4
35. Krymchantowski AV, Silva MT, Barbosa JS, et al. Amitriptilyne versus amitriptilyne combined with fluoxetine in the preventive treatment of trasformed migraine: a double-blind study. Headache 2002; 42:510-4
36. Silberstein SD, Peres MF, Hopkins MM, et al. Olanzapine in the treatment of refractory migraine and chronic daily headache. Headache 2002; 42:515-8
37. Saper JR, Lake AE III, Cantrell DT, et al. Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study. Headache 2002; 42:470-82
38. Coloprisco G, De Filippis S, Santi PG, et al. Reduction in expenditures on analgesics during one year of treatment of Chronic tension Headache with BoNT-A. J Headache Pain 2003; 4:88-91
39. Katzarava Z, Limmroth V, Finke M, et al. Rate and predictors for relapses in medication overuse headache: a one year prospective study. Neurology 2003; 60:1682-84
40. Katzarava Z, Müssig M, Dzagnidze A, et al. Medication overuse headache: rates and predictors for relapse in: a 4 year prospective study. Cephalalgia 2004; 25:12-5
41. Martelletti P. Pharmacoeconomics of migraine. J Headache Pain 2002; 3:54
42. Iannazzo S, Cattaruzza MS, De Filippis S, et al. Analgesic therapy for headache: consumption, appropriateness and costs. J Headache Pain 2003; 4(suppl 1):S85-88